ADA and retinal vasculitis: Anti-drug antibodies (ADA) existed in about 35–50% of the treatment naive eyes in the HAWK and HARRIER trials which could be the reason for antigen-antibody immune complex deposition and subsequent type-III hypersensitivity reaction which is postulated to be reason for IOI and retinal vasculitis.[32]